ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

THNK Think Research Corporation

0.315
0.00 (0.00%)
02 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Think Research Corporation TSXV:THNK TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.315 0.315 0.32 0 01:00:00

Think Research Corporation Announces Extension of Debt Facility with ScotiaBank

04/04/2023 12:10pm

PR Newswire (Canada)


Think Research (TSXV:THNK)
Historical Stock Chart


From Jul 2022 to Jul 2024

Click Here for more Think Research Charts.

TORONTO, April 4, 2023 /CNW/ - Think Research Corporation (TSXV: THNK) ("Think" or the "Company"),  a company focused on transforming healthcare through digital health software solutions, is pleased to announce that today it has extended its existing credit agreement (the " Credit Agreement") with The Bank of Nova Scotia ("BNS" or the "Lender") for an additional year.

Think Research Corporation Logo (CNW Group/Think Research Corporation)

Other than the extension, the Credit Agreement remains materially unchanged.

About Think Research Corporation

Think Research Corporation is an industry leader in delivering knowledge-based digital health software solutions. The Company's focused mission is to organize the world's health knowledge so everyone gets the best care. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, to facilitate better health care outcomes. The Company gathers, develops, and delivers knowledge-based solutions globally to customers which typically includes enterprise clients, hospitals, health regions, healthcare professionals, and / or governments. The Company has gathered a significant amount of data by building its repository of knowledge through its network and group of companies, including acquired companies.

Think licenses its solutions to over 13,000 facilities for over 300,000 primary care, acute care, and long-term care doctors, nurses and pharmacists that rely on the content and data provided by Think to support their practices. Millions of patients and residents annually receive better care due to the essential data that Think produces, manages and delivers.

In addition, the Company collects and manages pharmaceutical and clinical trial data via the BioPharma Services entity that Think acquired on September 10, 2021. BioPharma Services is a leading provider of bioequivalence and Phase 1 clinical research services to pharmaceutical companies globally. Think's other services include a network of digital-first primary care clinics and medical clinics that provide elective surgery. Visit: www.thinkresearch.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

For more information: https://www.thinkresearch.com/ca/investors/

SOURCE Think Research Corporation

Copyright 2023 Canada NewsWire

1 Year Think Research Chart

1 Year Think Research Chart

1 Month Think Research Chart

1 Month Think Research Chart

Your Recent History

Delayed Upgrade Clock